Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 6 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Apogee Therapeutics Inc have a median target of 84.00, with a high estimate of 95.00 and a low estimate of 75.00. The median estimate represents a 58.64% increase from the last price of 52.95.
High | 79.4% | 95.00 |
Med | 58.6% | 84.00 |
Low | 41.6% | 75.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate | +7.62% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼